Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Alcami announced the expanded deployment of its Extended Workbench laboratory services program to support the ongoing manufacturing and development of ZILRETTA.
read more
Alcami and the UNCW have been awarded an educational grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals.
read more
Aldena Therapeutics, a private biotech company pioneering siRNA- based therapies for dermatological indications, has chosen PCI Pharma Services (PCI), a global contract development and manufacturing organization (CDMO) to formulate, package, and ...
read more
Aldevron announced its new fermentation capacity of 1,000 liters and plans to increase the Company’s manufacturing footprint in Madison, WI.
read more
Aldevron announced its expansion plans for its Freiburg, Germany facility.
read more
Thursday, October 03, 2019
Aldevron has added GMP gene synthesis to its array of services.
read more
Aldevron has hired Vijay Surapaneni as its Vice President of Biomanufacturing Operations. This is a new position and is a part of the senior management team.
read more
Wednesday, February 17, 2016
Aldevron, a provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, announces the appointment of Jenny Stafford as Vice President and General Manager. Ms. Stafford’s responsibilities include ...
read more
Aldevron, has successfully completed the manufacturing of the TUSC2 plasmid DNA pursuant to the manufacturing agreement between Genprex and Aldevron that was announced in September 2018.
read more
Aldevron will expand its mRNA production capabilities to include lipid nanoparticle(LNP) encapsulation and aseptic fill-finish capabilities enabling mRNA cGMP manufacturing services from Master Cell Bank through to Drug Product.
read more
Don Kania, Ph.D., has been appointed to the Board of Directors of Aldevron, a global provider of plasmid DNA manufacturing, protein production and antibody discovery services.
read more
Aldevron has announced expansion plans for a 14-acre campus at its headquarters in Fargo, N.D.
read more
Tuesday, December 12, 2017
Aldevron announced a license agreement whereby Aldevron will manufacture and distribute a S. pyogenes Cas9 variant which is patented by IDT.
read more
Aleafia Health’s indirect subsidiary, Emblem Germany GmbH, has formally submitted its application to German regulators for EU Good Manufacturing Practices (EU-GMP) certification.
read more
Alembic is voluntarily recalling one lot of Telmisartan Tablets, USP, 20 mg, packaged in 30-count bottles, Lot No. 1905005661 to the consumer level.
read more